The UALCAN database showed that the transcript level of IGF2BP3 was higher in the primary bladder urothelial carcinoma (n = 408) than that in the normal samples (n = 19) (P = 0.0001, Fig. 5A). This evidence concerns the gene IGF2BP3 and bladder transitional cell carcinoma.